These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32942974)

  • 21. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
    Nai Y; Pan C; Hu X; Ma Y
    Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
    Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
    PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
    Huang S; Guo H; Cao Y; Xiong J
    Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
    Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
    Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
    Bhatti I; Lee A; James V; Hall RI; Lund JN; Tufarelli C; Lobo DN; Larvin M
    J Gastrointest Surg; 2011 Jan; 15(1):199-208. PubMed ID: 21088996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.
    Song W; Wang L; Wang L; Li Q
    Tumour Biol; 2015 Jun; 36(6):4741-5. PubMed ID: 25623117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
    Kent OA; Mullendore M; Wentzel EA; López-Romero P; Tan AC; Alvarez H; West K; Ochs MF; Hidalgo M; Arking DE; Maitra A; Mendell JT
    Cancer Biol Ther; 2009 Nov; 8(21):2013-24. PubMed ID: 20037478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-140 regulates cell growth and invasion in pancreatic duct adenocarcinoma by targeting iASPP.
    Liang S; Gong X; Zhang G; Huang G; Lu Y; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):174-81. PubMed ID: 26787707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.
    Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M
    Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
    Wang W; Li X; Guan C; Hu Z; Zhao Y; Li W; Jiang X
    Pathol Res Pract; 2020 Sep; 216(9):153074. PubMed ID: 32825947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.
    Kimura H; Sada R; Takada N; Harada A; Doki Y; Eguchi H; Yamamoto H; Kikuchi A
    Oncogene; 2021 Jul; 40(26):4486-4502. PubMed ID: 34117362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
    He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
    PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
    Roca MS; Moccia T; Iannelli F; Testa C; Vitagliano C; Minopoli M; Camerlingo R; De Riso G; De Cecio R; Bruzzese F; Conte M; Altucci L; Di Gennaro E; Avallone A; Leone A; Budillon A
    J Exp Clin Cancer Res; 2022 Mar; 41(1):83. PubMed ID: 35241126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma.
    Wu Z; Zhou L; Ding G; Cao L
    Cancer Biomark; 2017; 18(1):35-39. PubMed ID: 27814273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-497 inhibits cell proliferation and invasion ability by targeting HMGA2 in pancreatic ductal adenocarcinoma.
    Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.
    Lahdaoui F; Delpu Y; Vincent A; Renaud F; Messager M; Duchêne B; Leteurtre E; Mariette C; Torrisani J; Jonckheere N; Van Seuningen I
    Oncogene; 2015 Feb; 34(6):780-8. PubMed ID: 24608432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Oncogenic Targets Controlled by Tumor-Suppressive
    Nepal P; Hozaka Y; Tanaka T; Wada M; Asai S; Minemura C; Idichi T; Arigami T; Kurahara H; Seki N; Ohtsuka T
    Anticancer Res; 2021 Oct; 41(10):4821-4836. PubMed ID: 34593431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.